China Underground > All the latest news about China > China’s Clover raises $230 million, plans vaccines for COVID-19 variantsChina’s Clover raises $230 million, plans vaccines for COVID-19 variants February 22, 2021 by EditorialistaShare this:TwitterFacebookEmailLinkedInPinterestPocketWhatsAppChina’s Clover Biopharmaceuticals, a developer of coronavirus vaccines, has raised $230 million from investors, including Singapore’s state investment firm Temasek Holdings, it said on Tuesday, as it …About Post AuthorTable of Contents1 About Post Author1.1 Editorialista 2 Share this:3 Like this: Editorialista Send us your press release. China-underground.com helps clients reach all their key audiences – including industry professionals, decision-makers, journalists, researchers, and the public. Contact. See author's posts Share this:TwitterFacebookEmailLinkedInPinterestPocketWhatsAppLike this:Like Loading...Related posts: Trump takes final swipes at China’s big companies The ‘clink clink’ of your New Year’s Eve toast has an icy backstory Guizhou: Western province looks to the future of big data Mark Chao poses for photo shootSubscribe to China Underground and get the free magazine 'Planet China'* indicates required Email Address * View previous campaigns. Terms & ConditionsBy clicking Sign Up, you agree to our terms and conditions. Agree You can unsubscribe at any time by clicking the link in the footer of our emails.We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.